dalfopristin   Click here for help

GtoPdb Ligand ID: 10797

Synonyms: RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin)
Approved drug PDB Ligand
dalfopristin is an approved drug (FDA (1999))
Compound class: Synthetic organic
Comment: Dalfopristin is a semi-synthetic derivative of streptogramin A. It inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit. It is administered intravenously.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 184.8
Molecular weight 690.33
XLogP 1.7
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CCN(CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc1nc(C2=O)co1)O)/C)CC
Isomeric SMILES CCN(CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc1nc(C2=O)co1)O)/C)CC
InChI InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1
No information available.
Summary of Clinical Use Click here for help
Dalfopristin is intravenously administered in fixed combination with quinupristin to treat severe bacterial infections due to susceptible organisms including methicillin resistant Staphylococcus aureus (MRSA) or Streptococcus pyogenes.
External links Click here for help